ramosetron has been researched along with mebeverine in 2 studies
Studies (ramosetron) | Trials (ramosetron) | Recent Studies (post-2010) (ramosetron) | Studies (mebeverine) | Trials (mebeverine) | Recent Studies (post-2010) (mebeverine) |
---|---|---|---|---|---|
194 | 94 | 83 | 138 | 48 | 45 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bak, YT; Choi, MK; Choi, SC; Huh, KC; Kim, NY; Kwon, JK; Lee, JS; Lee, KJ; Lee, OY; Myung, SJ; Park, HJ; Rhee, PL; Sohn, CI | 1 |
Clavé, P | 1 |
1 trial(s) available for ramosetron and mebeverine
Article | Year |
---|---|
Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine.
Topics: Adolescent; Adult; Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Middle Aged; Parasympatholytics; Phenethylamines; Republic of Korea; Serotonin 5-HT3 Receptor Antagonists; Treatment Outcome; Young Adult | 2011 |
1 other study(ies) available for ramosetron and mebeverine
Article | Year |
---|---|
Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: similar therapeutical effects from heterogeneous pharmacological targets.
Topics: Benzimidazoles; Diarrhea; Humans; Irritable Bowel Syndrome; Male; Parasympatholytics; Phenethylamines; Serotonin 5-HT3 Receptor Antagonists | 2011 |